• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.98%

    Adamas Pharmaceuticals, Inc. (ADMS)

    -NasdaqGM
    26.54 Up 0.39(1.49%) Jul 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:26.15
    Open:26.17
    Bid:21.51 x 500
    Ask:26.61 x 600
    1y Target Est:35.50
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:25.41 - 27.12
    52wk Range:13.60 - 30.86
    Volume:99,133
    Avg Vol (3m):167,413
    Market Cap:503.01M
    P/E (ttm):155.20
    EPS (ttm):0.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADMS

    Comparison

    Symbol% ChgMkt Cap
    ADMSUp 1.49%503.01M
    IPXL 0.00%3.53B
    NVSUp 1.23%248.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.99
    Quarterly EPS Est (Jun-15) :-0.72
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback